These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 27038523

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Influence of xanthine oxidoreductase inhibitor, topiroxostat, on body weight of diabetic obese mice.
    Nakamura T, Nampei M, Murase T, Satoh E, Akari S, Katoh N, Mizukami H.
    Nutr Diabetes; 2021 Apr 13; 11(1):12. PubMed ID: 33850106
    [Abstract] [Full Text] [Related]

  • 4. Renoprotective effect of the xanthine oxidoreductase inhibitor topiroxostat on adenine-induced renal injury.
    Kamijo-Ikemori A, Sugaya T, Hibi C, Nakamura T, Murase T, Oikawa T, Hoshino S, Hisamichi M, Hirata K, Kimura K, Shibagaki Y.
    Am J Physiol Renal Physiol; 2016 Jun 01; 310(11):F1366-76. PubMed ID: 27029427
    [Abstract] [Full Text] [Related]

  • 5. Xanthine oxidoreductase inhibitor topiroxostat ameliorates podocyte injury by inhibiting the reduction of nephrin and podoplanin.
    Zhang Y, Fukusumi Y, Kayaba M, Nakamura T, Sakamoto R, Ashizawa N, Kawachi H.
    Nefrologia (Engl Ed); 2021 Jun 01; 41(5):539-547. PubMed ID: 36165136
    [Abstract] [Full Text] [Related]

  • 6. Uricosuric agents decrease the plasma urate level in rats by concomitant treatment with topiroxostat, a novel xanthine oxidoreductase inhibitor.
    Taniguchi T, Ashizawa N, Matsumoto K, Iwanaga T, Saitoh K.
    J Pharm Pharmacol; 2016 Jan 01; 68(1):76-83. PubMed ID: 26589240
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Topiroxostat improves glomerulosclerosis in type 2 diabetic Nagoya Shibata Yasuda mice with early diabetic kidney disease.
    Hagiwara M, Ishiyama S, Nakamura T, Mochizuki K.
    Eur J Pharmacol; 2024 Nov 05; 982():176915. PubMed ID: 39154822
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The effects of topiroxostat on vascular function in patients with hyperuricemia.
    Higa S, Shima D, Tomitani N, Fujimoto Y, Kario K.
    J Clin Hypertens (Greenwich); 2019 Nov 05; 21(11):1713-1720. PubMed ID: 31556223
    [Abstract] [Full Text] [Related]

  • 13. Effect of switching xanthine oxidoreductase inhibitor from febuxostat to topiroxostat on urinary protein excretion.
    Terawaki H, Hoshi H, Kazama JJ.
    Clin Exp Nephrol; 2017 Apr 05; 21(2):356-357. PubMed ID: 28247173
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparative effects of topiroxostat and febuxostat on arterial properties in hypertensive patients with hyperuricemia.
    Kario K, Nishizawa M, Kiuchi M, Kiyosue A, Tomita F, Ohtani H, Abe Y, Kuga H, Miyazaki S, Kasai T, Hongou M, Yasu T, Kuramochi J, Fukumoto Y, Hoshide S, Hisatome I.
    J Clin Hypertens (Greenwich); 2021 Feb 05; 23(2):334-344. PubMed ID: 33400348
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Xanthine oxidoreductase activity assay in tissues using stable isotope-labeled substrate and liquid chromatography high-resolution mass spectrometry.
    Murase T, Nampei M, Oka M, Ashizawa N, Matsumoto K, Miyachi A, Nakamura T.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jan 01; 1008():189-197. PubMed ID: 26673227
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Randomized control trial for the assessment of the anti-albuminuric effects of topiroxostat in hyperuricemic patients with diabetic nephropathy (the ETUDE study).
    Kato S, Ando M, Mizukoshi T, Nagata T, Katsuno T, Kosugi T, Tsuboi N, Maruyama S.
    Nagoya J Med Sci; 2016 May 01; 78(2):135-42. PubMed ID: 27303100
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.